Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Fujitsu Launches Japan's First System for Automatically Generating Electronic Submission Data for Pharmaceuticals

Thursday, October 31, 2019

Fujitsu Limited today announced that it has developed tsClinical for SDTM Automation a solution for pharmaceutical companies that automatically converts electronic study data to the standardized Study Data Tabulation Model SDTM format

Vetter Provides Greater Flexibility in Secondary Packaging Through Collaborative Work

Thursday, October 31, 2019

Vetters core competencies include the manufacturing of safe userfriendly complex packaging systems such as the assembly of pens autoinjectors and safety devices Thanks to the many years of experience and expert knowledge of its employees the contract...

SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor

Wednesday, October 30, 2019

SeraNovo BV announced that it has signed a License Agreement with Carna Biosciences Inc a company engaged in drug development specializing in the development of kinase inhibitors Under the agreement the companies will expand their existing collaborat...

Galimedix Therapeutics, Inc.’s GAL-101 Gains from Target Validation by Positive Phase 3 Results of Biogen’s Aducanumab

Wednesday, October 30, 2019

Galimedix Therapeutics Inc an emerging leader in the development of new solutions for neurodegenerative diseases of the retina and the brain today announced that the recent positive results of a Phase study in Alzheimers disease with Biogens aducanu...

Terns Pharmaceuticals Receives Fast Track Designation From the FDA for TERN-101, an FXR Agonist for the Treatment of NASH

Wednesday, October 30, 2019

Terns Pharmaceuticals Inc a global biopharmaceutical company focused on discovering and developing innovative therapies to treat nonalcoholic steatohepatitis NASH and cancer today announced that TERN an investigational farnesoid X receptor FXR agonis...

SFA Therapeutics, Inc. Receives an FDA Orphan Drug Designation (ODD) for SFA001 in the Treatment of Hepatocellular Carcinoma (HCC)

Tuesday, October 29, 2019

SFA Therapeutics Inc announced today that FDA has granted an official Orphan Drug Designation ODD to SFA the companys novel humanmicrobiomebased treatment for human hepatocellular carcinoma HCC

Mirum Pharmaceuticals Announces Breakthrough Therapy Designation for Maralixibat for the Treatment of Pruritus Associated with Alagille Syndrome

Tuesday, October 29, 2019

Mirum Pharmaceuticals Inc a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases today announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy De...

BioMed X Completes Alzheimer’s Disease Research Project

Monday, October 28, 2019

BioMed X announced today the successful completion of their first research collaboration project with AbbVie in the field of taumediated neurodegeneration in Alzheimers disease BioMed X received a milestone payment and the results of the project were...

Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals

Monday, October 28, 2019

Sundial Growers Inc a Canadian licensed producer of cannabis and Crescita Therapeutics Inc and a Canadian commercial dermatology company today announced a development and licensing agreement the Agreement granting Sundial the worldwide rights to Cre...

Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health

Friday, October 25, 2019

The implementation of the Healthy China Planning Outline has ushered in rapid development of Chinas big health industry with the industry scale expected to reach RMB trillion in and RMB trillion in calculated as per the about compound annual grow...